Colin O’Leary is a PhD candidate in the Program in Virology at Harvard Medical School, where he researches emerging and reemerging viral diseases, utilizes systems and synthetic biology approaches to study host-pathogen interaction, and develops novel antiviral technologies and countermeasures. He previously worked as a student research assistant with the Technology and Public Purpose Program at Harvard’s Belfer Center and published on medical countermeasure research and development and vaccine equity. Colin completed a B.S. in biology and politics at Bates College.
T. Anders Olsen
T. Anders Olsen is a first-year Master’s in Public Policy student at the Harvard Kennedy School and, prior to this, was finishing his last year of medical school at the Emory School of Medicine. He is interested in applying to internal medicine for residency and pursuing a career in medical oncology. He was born and raised in Atlanta, Georgia, and has been there most of his life. He has been interested in policy, specifically health policy, since starting his undergraduate degree at Emory University where he studied health economics and wrote an honor’s thesis studying the effect of Medicaid expansion on hospital revenues. His aspiration with his Master’s degree is to pursue a career at the intersection of health policy and oncology, specifically in the realm of healthcare costs, drug pricing and novel drug innovation. In his free time, he enjoys playing the violin and ultimate frisbee. He also loves cooking, live music, and any outdoor activity he can do with friends.
Sanjay Reddy is currently a JD/MPP candidate at Georgetown University Law Center and Harvard Kennedy School. Previously, he served as a legislative aide to U.S. Rep. Haley Stevens (D-MI). In this capacity, he advised the Congresswoman on a variety of policy issues, including health policy related to the House Education & Labor Subcommittee on Health, Employment, Labor and Pensions (HELP). He has also worked as a law clerk for the U.S. Attorney’s Office for the District of Maryland with a focus on health fraud and FDA-related investigations and as a data analyst for Tempus Labs, a health-technology startup. He earned a B.S. in Cell and Molecular Biology from the University of Michigan, where he was a member of Phi Beta Kappa.